Combining tirzepatide with the experimental drug eloralintide produced substantially greater weight loss than tirzepatide alone in a phase 2 trial of adults with type 2 diabetes, though side effects and dropout rates were higher.
Tirzepatide Plus Eloralintide Yields 23% Weight Loss in Trial
Combining tirzepatide with the experimental drug eloralintide produced substantially greater weight loss than tirzepatide alone in a phase 2 trial of adults with type 2 diabetes, though side effects and dropout rates were higher.
Monitoring item. The full text is not distributed. Extract and source below.
Same event, other desks
Story file →
fr
M. Night Shyamalan dévoile « Remain » à Beyond Fest et les premières réactions saluent Jake Gyllenh…
30.09 15:00
de
End of Abyss: Atmosphärischer Horror im Test
30.09 15:01
en
Lady A's Charles Kelley Reveals Multiple Myeloma Diagnosis
30.09 15:01